中西医药物干预糖尿病前期的研究进展  

Research Progress of Traditional Chinese and Western Medicine in the Intervention of Prediabetes

作　　者：王彬言 张珊珊[2] WANG Binyan;ZHANG Shanshan(College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Shandong Province,Ji’nan 250000,China;Department of Endocrinology,Shandong Provincial Hospital of Traditional Chinese Medicine,Shandong Province,Ji’nan 250000,China)

机构地区：[1]山东中医药大学中医学院,山东济南250000 [2]山东省中医院内分泌科,山东济南250000

出　　处：《中国中医药现代远程教育》2023年第2期205-206,I0001,F0004,共4页Chinese Medicine Modern Distance Education of China

摘　　要：糖尿病前期是正常人进展为糖尿病的必经阶段,也是预防和延缓糖尿病发生的关键时期。生活方式干预是目前糖尿病前期治疗的主要手段,但仍存在缺陷,药物干预糖尿病前期的研究已逐步成为重点。其中,西医药物主要包括阿卡波糖、二甲双胍等,中医药物则分为复方、中成药等多种形式。此文分析近年的相关文献,对药物干预糖尿病前期及其研究提供依据。Prediabetes is the necessary stage for normal people to develop into diabetes mellitus,and it is also the key period to prevent and delay the occurrence of diabetes.Lifestyle intervention is currently the main method of pre-diabetes treatment,but there are still shortcomings.Research on drug intervention in pre-diabetes has gradually become the focus.Among them,western medicines mainly include acarbose,metformin,etc.Traditional Chinese medicines are divided into multiple forms such as compound prescriptions and proprietary Chinese medicines.This article analyzes the relevant literature in recent years to provide evidence for drug intervention in prediabetes and its research.

关 键 词：糖尿病前期 中西医药物 综述 

分 类 号：R587.1[医药卫生—内分泌]